首页|不同诱导剂量咪达唑仑在甲状腺癌根治术中的麻醉效果

不同诱导剂量咪达唑仑在甲状腺癌根治术中的麻醉效果

扫码查看
目的 研究不同诱导剂量咪达唑仑在甲状腺癌根治术中的麻醉效果和对患者苏醒质量的影响。方法 选取接受甲状腺癌根治术的患者160例,利用计算机生成的随机数列分为A组、B1组、B2组和B3组,每组40例。对患者进行麻醉诱导时,A组不应用咪达唑仑,B1组、B2组和B3组分别静脉注射0。05、0。10、0。15 mg·kg-1咪达唑仑。比较4组血流动力学指标[平均动脉压(mean arterial pressure,MAP)、血氧饱和度(blood oxygen saturation,SpO2)和心率(heart rate,HR)]、苏醒指标、视觉模拟评分(visual analogue score,VAS)、镇静程度评估表(richmond agitation-sedation scale,RASS)和简易精神状态检查表(mini-mental state examination,MMSE)。结果 B1组、B2组和B3组 在麻醉诱导后(t1)、手术结束(t2)MAP、HR高于A组,B2组t2 MAP、HR高于B1组、B3组;B1组、B2组和B3组t2 SpO2 低于A组,B2组t2 SpO2 低于B1组、B3组(P<0。05);术后第 3天B1组、B2组和B3组VAS评分低于A组(P<0。05),B2组VAS评分低于B1组、B3组(P<0。05);躁动发生率B1组、B2组和B3组显著低于A组(P<0。05),B2组、B3组低于B1组(P<0。05);苏醒时间B1组、B2组和B3组早于A组,B2组早于B1组、B3组(P<0。05);B1组、B2组和B3组t2、t3(手术结束12 h)、t4(手术结束后24 h)RASS评分明显低于A组(P<0。05),B2组低于B1组、B3组(P<0。05);B1组、B2组和B3组术后3 d MMSE评分均低于A组(P<0。05),B2组高于B1组、B3组(P<0。05)。结论 在甲状腺癌根治术中麻醉诱导时应用0。10 mg·kg-1咪达唑仑,镇静作用好,疼痛程度低,苏醒质量好,值得临床推广。
Anesthetic effect of different induction doses of midazolam in radical thyroidectomy
Objective To study the anesthetic effect of different induction doses of midazolam in radical thyroidectomy and its effect on the quality of awakening.Methods A total of 160 patients undergoing radical thyroidectomy were randomly divided into group A,group B1,group B2 and group B3,with 40 patients in each group.During anesthesia induction,group A did not use midazolam,while group B1,group B2 and group B3 received intravenous injection of 0.05,0.10 and 0.15 mg·kg-1 midazolam respectively.The hemodynamic indexes mean arterial pressure(MAP),blood oxygen saturation(SpO2)and heart rate(HR),awakening indexes,visual analogue score(VAS),Richmond agitation-sedation scale(RASS)and mini-mental state examination(MMSE)were compared among the 4 groups.Results The t1(after anesthesia induction),t2(operation end),MAP and HR in B1,B2 and B3 groups were higher than those in group A,while the t2 MAP and HR in group B2 were higher than those in group B1 and B3.The t2 SpO2 in group B1,B2 and B3 was lower than that in group A,and t2 SpO2 in group B2 was lower than that in group B1 and B3(P<0.05).On the third day after operation,the VAS scores of group B1,group B2 and group B3 were lower than those of group A(P<0.05),and the VAS scores of group B2 were lower than those of group B1 and group B3(P<0.05).The incidence of restlessness in group B1,B2 and B3 was significantly lower than that in group A(P<0.05),and that in group B2 and B3 was lower than that in group B1(P<0.05).The awakening time of group B1,B2 and B3 was earlier than that of group A,and that of group B2 was earlier than that of group B1 and B3(P<0.05).The t2,t3(postoperative end 12 hours),t4(postoperative end 24 hours)RASS scores of group B1,group B2 and group B3 were significantly lower than those of group A(P<0.05),while those of group B2 were lower than those of group B1 and group B3(P<0.05).The postoperative 3-day MMSE scores of group B1,group B2 and group B3 were lower than those of group A(P<0.05),while those of group B2 were higher than those of group B1 and group B3(P<0.05).Conclusion Using 0.10 mg·kg-1 midazolam during anesthesia induction in radical thyroidectomy for thyroid cancer has good sedative effect,low degree of pain and good quality of awakening,which is worthy of clinical promotion.

midazolamradicalthyroidectomyanesthesiaawakening quality

郑超、何迎春

展开 >

商丘市第三人民医院麻醉科,商丘 476000

咪达唑仑 甲状腺癌根治术 麻醉 苏醒质量

河南省自然科学基金项目

182300410382

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(3)
  • 19